Shree Ganesh Remedies Ltd (SGRL) is currently trading at 665.65 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Shree Ganesh Remedies Limited specializes in manufacturing pharmaceutical intermediates and specialty chemicals, serving global markets. Over 20 years in operation, it has built extensive expertise in complex chemical synthesis, affirming its role as a trusted partner for leading global companies. The company experienced a challenging quarter with a 22% YoY decline in revenue due to shipment delays and tough European market conditions. Management, however, remains optimistic about a business turnaround in FY27 with new pilot facilities boosting product development. A strategic focus on capacity expansion is evident with new expansions at Ankleshwar and Dahej sites, targeting large-scale production capabilities. This aligns with their plan to meet growing demands and maintain competitive edge. Investment in innovation is ongoing with state-of-the-art R&D facilities driving product development. The company is also recognized for its excellence with multiple compliance certificates, ensuring product quality and reliability.

Over the past 52 weeks, Shree Ganesh Remedies Ltd has traded between a low of ₹381.10 and a high of ₹759.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Shree Ganesh Remedies Ltd has a market capitalization of approximately 896.19. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Shree Ganesh Remedies Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 58.04 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 896.19 Cr, Shree Ganesh Remedies Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Shree Ganesh Remedies Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Shree Ganesh Remedies Ltd is 58.04. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Net profit after tax (PAT) was ₹1.12 crore for the quarter ended June 30, 2026, down 67.5% year-on-year from ₹3.45 crore.